What is Rosetta Genomics?
Rosetta Genomics specializes in providing comprehensive information and resources concerning cancer. The company's offerings include a blog that delves into cancer treatment modalities, practical healthy living tips, and detailed explanations of the complexities surrounding cancer as a disease. Their primary objective is to educate and foster greater awareness about cancer-related issues, targeting individuals actively seeking knowledge and management strategies for cancer.
How much funding has Rosetta Genomics raised?
Rosetta Genomics has raised a total of $26.3M across 1 funding round:
Stock Offering
$26.3M
Stock Issuance/Offering (2007): $26.3M, investors not publicly disclosed
What's next for Rosetta Genomics?
The substantial enterprise-level funding, coupled with the recent strategic investment, positions Rosetta Genomics for accelerated growth and expanded reach. This capital infusion is expected to fuel further development of their informational resources and outreach programs, reinforcing their role as a key player in cancer education and awareness. The company is poised to enhance its platform, potentially exploring new avenues for disseminating critical health information and supporting patient communities.
See full Rosetta Genomics company page
